The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Latz, E.
Right arrow Articles by Schreiber, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Latz, E.
Right arrow Articles by Schreiber, J. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
The Journal of Immunology, 2004, 172: 2431-2438.
Copyright © 2004 by The American Association of Immunologists

Haemophilus influenzae Type b-Outer Membrane Protein Complex Glycoconjugate Vaccine Induces Cytokine Production by Engaging Human Toll-Like Receptor 2 (TLR2) and Requires the Presence of TLR2 for Optimal Immunogenicity1

Eicke Latz*, Jennifer Franko{dagger},{ddagger}, Douglas T. Golenbock* and John R. Schreiber2,{dagger},{ddagger}

* Department of Medicine, University of Massachusetts Medical Center, Worcester, MA 01605; {dagger} Departments of Pediatrics and Pathology, Case Western Reserve University, and {ddagger} Division of Infectious Diseases, Rainbow Babies and Children’s Hospital, Cleveland OH 44106

Conjugate vaccines consisting of the capsular polysaccharide (PS) of Haemophilus influenzae type b (Hib) covalently linked to carrier proteins, unlike pure PS, are immunogenic in infants and have significantly reduced Hib infections in the United States, but require multiple doses to induce protective anti-PS Ab titers. Hib-meningococcal outer membrane protein complex (OMPC) conjugate vaccine, however, elicits protective anti-PS Ab titers after one dose. We found that OMPC and Hib-OMPC engaged human Toll-like receptor 2 (TLR2) expressed in human embryonic kidney (HEK) cells, inducing IL-8 production, and engaged mouse TLR2 on bone marrow-derived dendritic cells, inducing TNF release. Hib conjugated to the carrier proteins CRM197 and tetanus toxoid did not engage TLR2 on HEK or dendritic cells. Engagement of TLR2 by Hib-OMPC was MyD88 dependent, as Hib-OMPC-induced TNF production was ablated in MyD88 knockout (KO) mice. Hib-OMPC was significantly less immunogenic in TLR2 KO mice, inducing lower Hib PS IgG and IgM titers compared with those in wild-type mice. Splenocytes from OMPC-immunized TLR2 KO mice also produced significantly less IL-6 and TNF-{alpha} than those from wild-type mice. Hib-OMPC is unique among glycoconjugate vaccines by engaging TLR2, and the ability of Hib-OMPC to elicit protective levels of Abs after one dose may be related to TLR2-mediated induction and regulation of cytokines produced by T cells and macrophages in addition to the peptide/MHC II-dependent recruitment of T cell help commonly afforded by carrier proteins. TLR2 engagement by an adjuvant or carrier protein may be a useful strategy for augmentation of the anti-PS Ab response induced by glycoconjugate vaccines.


Related articles in The JI:

IN THIS ISSUE

The JI 2004 172: 1989-1990. [Full Text]  



This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
T. H. Mogensen
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Clin. Microbiol. Rev., April 1, 2009; 22(2): 240 - 273.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. G. Joyce, I. J. Krauss, H. C. Song, D. W. Opalka, K. M. Grimm, D. D. Nahas, M. T. Esser, R. Hrin, M. Feng, V. Y. Dudkin, et al.
An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions
PNAS, October 14, 2008; 105(41): 15684 - 15689.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
D. Chiavolini, S. Weir, J. R. Murphy, and L. M. Wetzler
Neisseria meningitidis PorB, a Toll-Like Receptor 2 Ligand, Improves the Capacity of Francisella tularensis Lipopolysaccharide To Protect Mice against Experimental Tularemia
Clin. Vaccine Immunol., September 1, 2008; 15(9): 1322 - 1329.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Leendertse, R. J. L. Willems, I. A. J. Giebelen, P. S. van den Pangaart, W. J. Wiersinga, A. F. de Vos, S. Florquin, M. J. M. Bonten, and T. van der Poll
TLR2-Dependent MyD88 Signaling Contributes to Early Host Defense in Murine Enterococcus faecium Peritonitis
J. Immunol., April 1, 2008; 180(7): 4865 - 4874.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Cohen, M. Stolarsky-Bennun, H. Amir-Kroll, R. Margalit, G. Nussbaum, M. Cohen-Sfady, M. Pevsner-Fischer, M. Fridkin, H. Bercovier, L. Eisenbach, et al.
Pneumococcal Capsular Polysaccharide Is Immunogenic When Present on the Surface of Macrophages and Dendritic Cells: TLR4 Signaling Induced by a Conjugate Vaccine or by Lipopolysaccharide Is Conducive
J. Immunol., February 15, 2008; 180(4): 2409 - 2418.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
F. Fransen, C. J. Boog, J. P. van Putten, and P. van der Ley
Agonists of Toll-Like Receptors 3, 4, 7, and 9 Are Candidates for Use as Adjuvants in an Outer Membrane Vaccine against Neisseria meningitidis Serogroup B
Infect. Immun., December 1, 2007; 75(12): 5939 - 5946.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Burke, L. M. Ganley-Leal, A. Khatri, and L. M. Wetzler
Neisseria meningitidis PorB, a TLR2 Ligand, Induces an Antigen-Specific Eosinophil Recall Response: Potential Adjuvant for Helminth Vaccines?
J. Immunol., September 1, 2007; 179(5): 3222 - 3230.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. D. Tachado, J. Zhang, J. Zhu, N. Patel, M. Cushion, and H. Koziel
Pneumocystis-mediated IL-8 release by macrophages requires coexpression of mannose receptors and TLR2
J. Leukoc. Biol., January 1, 2007; 81(1): 205 - 211.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Q. Wang, R. M. McLoughlin, B. A. Cobb, M. Charrel-Dennis, K. J. Zaleski, D. Golenbock, A. O. Tzianabos, and D. L. Kasper
A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2
J. Exp. Med., December 25, 2006; 203(13): 2853 - 2863.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Wu, C. Przysiecki, E. Flanagan, S. N. Bello-Irizarry, R. Ionescu, O. Muratova, G. Dobrescu, L. Lambert, D. Keister, Y. Rippeon, et al.
Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex
PNAS, November 28, 2006; 103(48): 18243 - 18248.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Chen, G. Sen, and C. M. Snapper
Endogenous IL-1R1 Signaling Is Critical for Cognate CD4+ T Cell Help for Induction of In Vivo Type 1 and Type 2 Antipolysaccharide and Antiprotein Ig Isotype Responses to Intact Streptococcus pneumoniae, but Not to a Soluble Pneumococcal Conjugate Vaccine
J. Immunol., November 1, 2006; 177(9): 6044 - 6051.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. H. Mogensen, S. R. Paludan, M. Kilian, and L. Ostergaard
Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns
J. Leukoc. Biol., August 1, 2006; 80(2): 267 - 277.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. Sen, Q. Chen, and C. M. Snapper
Immunization of Aged Mice with a Pneumococcal Conjugate Vaccine Combined with an Unmethylated CpG-Containing Oligodeoxynucleotide Restores Defective Immunoglobulin G Antipolysaccharide Responses and Specific CD4+-T-Cell Priming to Young Adult Levels
Infect. Immun., April 1, 2006; 74(4): 2177 - 2186.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Massari, A. Visintin, J. Gunawardana, K. A. Halmen, C. A. King, D. T. Golenbock, and L. M. Wetzler
Meningococcal Porin PorB Binds to TLR2 and Requires TLR1 for Signaling
J. Immunol., February 15, 2006; 176(4): 2373 - 2380.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Q. Khan, G. Sen, S. Guo, O. N. Witte, and C. M. Snapper
Induction of In Vivo Antipolysaccharide Immunoglobulin Responses to Intact Streptococcus pneumoniae Is More Heavily Dependent on Btk-Mediated B-Cell Receptor Signaling than Antiprotein Responses
Infect. Immun., February 1, 2006; 74(2): 1419 - 1424.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. A. Divekar, D. M. W. Zaiss, F. E.-H. Lee, D. Liu, D. J. Topham, A. J. A. M. Sijts, and T. R. Mosmann
Protein Vaccines Induce Uncommitted IL-2-Secreting Human and Mouse CD4 T Cells, Whereas Infections Induce More IFN-{gamma}-Secreting Cells
J. Immunol., February 1, 2006; 176(3): 1465 - 1473.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Yoshida, H. Jono, H. Kai, and J.-D. Li
The Tumor Suppressor Cylindromatosis (CYLD) Acts as a Negative Regulator for Toll-like Receptor 2 Signaling via Negative Cross-talk with TRAF6 and TRAF7
J. Biol. Chem., December 9, 2005; 280(49): 41111 - 41121.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Sen, A. Q. Khan, Q. Chen, and C. M. Snapper
In Vivo Humoral Immune Responses to Isolated Pneumococcal Polysaccharides Are Dependent on the Presence of Associated TLR Ligands
J. Immunol., September 1, 2005; 175(5): 3084 - 3091.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. Lorenz, D. C. Chemotti, A. L. Jiang, and L. D. McDougal
Differential Involvement of Toll-Like Receptors 2 and 4 in the Host Response to Acute Respiratory Infections with Wild-Type and Mutant Haemophilus influenzae Strains
Infect. Immun., April 1, 2005; 73(4): 2075 - 2082.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Q. Khan, Q. Chen, Z.-Q. Wu, J. C. Paton, and C. M. Snapper
Both Innate Immunity and Type 1 Humoral Immunity to Streptococcus pneumoniae Are Mediated by MyD88 but Differ in Their Relative Levels of Dependence on Toll-Like Receptor 2
Infect. Immun., January 1, 2005; 73(1): 298 - 307.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.